{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-007971","form_type":"8-K","ticker":null,"cik":"0001355250","company_name":"Innovation Pharmaceuticals Inc.","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.736706+00:00","generated_at":"2026-06-09T05:42:46.731760+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Innovation Pharmaceuticals changes independent auditor from Pinnacle to GreenGrowth CPAs","bullets":["On October 29, 2023, the Audit Committee dismissed Pinnacle Accountancy Group as the company's independent auditor, effective immediately.","The company engaged GreenGrowth CPAs as its new independent public accounting firm on the same date.","The change followed the sale of a portion of Pinnacle's public company accounting practice to GreenGrowth.","Pinnacle's reports for fiscal years ended June 30, 2023 and 2022 were unqualified except for a going concern explanatory paragraph.","The company reported a material weakness in internal control over financial reporting related to an unconsolidated foreign investment."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-007971","json":"https://secwatch.observer/filing/0001477932-23-007971.json","markdown":"https://secwatch.observer/filing/0001477932-23-007971.md","text":"https://secwatch.observer/filing/0001477932-23-007971.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1355250/000147793223007971/0001477932-23-007971-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1355250/000147793223007971/ipix_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T05:42:46.731760+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2b0b1ed7db3b99902bbf55e186c1286e5215b205","claim":"Innovation Pharmaceuticals Inc. dismissed Pinnacle Accountancy Group of Utah (a d/b/a of Heaton & Company, PLLC) as its auditor.","evidence_excerpt":"On October 29, 2023, the Audit Committee of the Board of Directors of Innovation Pharmaceuticals Inc. (the \"Company\") dismissed Pinnacle Accountancy Group of Utah (a d/b/a of Heaton & Company, PLLC) (\"Pinnacle\") as the Company's independent public accounting firm","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1355250/000147793223007971/0001477932-23-007971-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"Pinnacle Accountancy Group of Utah (a d/b/a of Heaton & Company, PLLC)"}],"fact_type":"auditor_change"},{"claim_id":"58eee2dd47e9fa494bfb884a7d85b3e2ebad351d","claim":"Innovation Pharmaceuticals Inc. engaged GreenGrowth CPAs as its auditor.","evidence_excerpt":"Also on October 29, 2023, the Audit Committee approved the engagement of GreenGrowth CPAs (\"GreenGrowth\") as the Company's new independent public accounting firm","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1355250/000147793223007971/0001477932-23-007971-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"GreenGrowth CPAs"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}